These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9416794

  • 1. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
    Little MP.
    Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
    [Abstract] [Full Text] [Related]

  • 2. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N, Charles MW.
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
    Kellerer AM, Nekolla E.
    Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W, Walsh L, Chomentowski M.
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [Abstract] [Full Text] [Related]

  • 7. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS, Endo S, Hoshi M, Nomura T.
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [Abstract] [Full Text] [Related]

  • 8. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
    Cordova KA, Cullings HM.
    Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
    [Abstract] [Full Text] [Related]

  • 9. The effects of neutrons in Hiroshima. Implications for the risk estimates.
    Kellerer AM.
    C R Acad Sci III; 1999 Aug; 322(2-3):229-37. PubMed ID: 10196677
    [Abstract] [Full Text] [Related]

  • 10. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M, Schull WJ.
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [Abstract] [Full Text] [Related]

  • 11. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS, Endo S, Ejima Y, Saito I, Okamura K, Oka Y, Hoshi M.
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [Abstract] [Full Text] [Related]

  • 12. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M, Schull WJ.
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [Abstract] [Full Text] [Related]

  • 13. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ.
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA.
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [Abstract] [Full Text] [Related]

  • 18. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
    Rühm W, Walsh L.
    Radiat Prot Dosimetry; 2007 Jun; 126(1-4):423-31. PubMed ID: 17533156
    [Abstract] [Full Text] [Related]

  • 19. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
    Hafner L, Walsh L, Rühm W.
    Int J Radiat Biol; 2024 Jun; 100(1):61-71. PubMed ID: 37772764
    [Abstract] [Full Text] [Related]

  • 20. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
    Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K.
    Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.